Saad A Alajmi

Dr. Saad A Alajmi

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 November 2025 in Medicina
Verified
Journal Article
Open access
PDF file
Abdullah M AlharranAbdullah M Alharran
Abdullah M Alharran
SASaad A Alajmi
Saad A Alajmi
AHAli A. Hussain
Ali A. Hussain
MAMohammad Salem Alajmi
Mohammad Salem Alajmi
SHSayed Hashim
Sayed Hashim
HAHusain Alaradi
Husain Alaradi
Background and Objectives: Retrograde intrarenal surgery (RIRS) is a cornerstone in managing upper urinary tract stones, with a growing trend towards instrument miniaturization. The introduction of the ultra-slim 6.3 Fr single-use flexible ureteroscope presents a potential advancement over the standard 7.5 Fr device, but clinical evidence remains scarce. This systematic review and meta-analysis aims to synthesize data from randomized controlled trials (RCTs) to compare the efficacy and safety of the 6.3 Fr versus the 7.5 Fr ureteroscope. Materials and Methods: A systematic search of PubMed, Scopus, CENTRAL, and Web of Science was conducted for RCTs published up to September 2025. The primary outcomes were the stone-free rate and procedural success rate. Secondary outcomes included operation duration and postoperative complications. Risk ratios (RRs) for dichotomous data and mean differences (MDs) for continuous data, with 95% confidence intervals (CIs), were pooled for analysis. Results: Three RCTs involving 140 patients were included. There was no significant difference between both groups in stone-free rates (RR: 1.06, 95% CI [0.96, 1.18], p = 0.22) or success rates (RR: 1.06, 95% CI [0.97, 1.16], p = 0.17). However, the 6.3 Fr ureteroscope was associated with a significantly shorter operation duration (MD: −6.66 min, 95% CI [−11.29, −2.03], p < 0.001). No significant differences were found in laser operating time (MD: −1.46 min, 95% CI [−3.93, 1.01], p = 0.25), length of hospital stay (MD: −0.09 days, 95% CI [−0.23, 0.05], p = 0.19), or postoperative complications (Clavien I: RR 0.86, 95% CI [0.30, 2.43], p = 0.77; Clavien II–III: RR 0.67, 95% CI [0.12, 3.84], p = 0.65). Conclusions: Based on low-certainty evidence, the 6.3 Fr ureteroscope does not significantly improve stone-free rates but may reduce overall operation duration compared to the 7.5 Fr scope, with a comparable safety profile. These findings are limited by the small number of available studies, highlighting a clear need for larger, high-quality RCTs to confirm these preliminary results.

1 January 2026 in Medicina
Verified
Journal Article
Open access
PDF file
Abdullah M AlharranAbdullah M Alharran
Abdullah M Alharran
WAWaleed Bader Alazemi
Waleed Bader Alazemi
SASaad A Alajmi
Saad A Alajmi
YBYousiff A Bahman
Yousiff A Bahman
OAOsamah Alhajri
Osamah Alhajri
DSDuaij Saif
Duaij Saif
Background and Objectives: Effective pain control after laparoscopic colorectal surgery is crucial for Enhanced Recovery After Surgery (ERAS) protocols. The transversus abdominis plane block (TAPB) provides somatic analgesia but lacks visceral coverage. The quadratus lumborum block (QLB) has emerged as an alternative, potentially offering both somatic and visceral blockade, but its superiority is debated. This systematic review and meta-analysis aimed to compare the analgesic efficacy of QLB versus TAPB in this setting. Materials and Methods: A comprehensive search of PubMed, Scopus, CENTRAL, and Web of Science was conducted for randomized controlled trials (RCTs) up to November 2025. Primary outcomes were 24 h postoperative and intraoperative opioid consumption. Secondary outcomes included pain scores, length of hospital stay (LoS), surgery duration, and adverse events. Standardized mean differences (SMD) and risk ratios (RR) were pooled. Results: Five RCTs involving 520 patients were included. No significant difference was found in 24 h postoperative opioid consumption (SMD: −1.62, 95% CI [−3.45, 0.20]; p = 0.08) or intraoperative opioid consumption (SMD: 0.38, 95% CI [−0.36, 1.12]; p = 0.31). QLB provided better, transient pain relief at rest at 12 h (SMD: −0.30, 95% CI [−0.52, −0.07]; p = 0.01) and during movement at 6 h (SMD: −0.20, 95% CI [−0.49, −0.09]; p = 0.01). No other time points for pain showed significant differences. QLB was associated with a shorter surgery duration (MD: −5.61 min, 95% CI [−10.38, −0.85]; p = 0.02), but not LoS (p = 0.53) or rates of PONV (p = 0.24) or dizziness (p = 0.32). Conclusions: With uncertain evidence, QLB and TAPB showed no significant difference in opioid consumption. QLB demonstrated a statistically significant but transient early analgesic advantage. This heterogeneity may be due to different QLB techniques, warranting further investigation.

2 September 2026 in Cureus
Verified
Journal Article
Open access
PDF file
SASaad A Alajmi
Saad A Alajmi
AAAli K. Alhilal
Ali K. Alhilal
AHAbdullah Hussain
Abdullah Hussain
SASaad Alajmi
Saad Alajmi
AJAli Alhilal Jr.
Ali Alhilal Jr.
Surgical site infection (SSI) is common after emergency laparotomy, and closed-incision prophylactic negative pressure wound therapy (ciNPWT) applied over the closed incision has been proposed to reduce it, though trials disagree. We searched MEDLINE, Embase, CENTRAL, Scopus, and two trial registries to 21 June 2026, with no date or language restriction, for randomized controlled trials (RCTs) comparing ciNPWT with standard dressings in adults undergoing emergency laparotomy. The primary outcome was any incisional SSI within 30 days. We used random-effects meta-analysis with restricted maximum likelihood, Hartung-Knapp-Sidik-Jonkman confidence intervals, and prediction intervals, together with RoB 2 and GRADE; because heterogeneity tracked study quality, we present the primary outcome stratified by risk of bias. Seven RCTs were included (1,351 patients; largest approximately 840), of which five contributed to the primary analysis and two to sensitivity analyses only - one because it reported outcomes only for a mixed elective and emergency whole cohort rather than an extractable emergency subgroup, and one because it was at high risk of bias with an implausibly high control-arm infection rate. The single trial at low risk of bias showed no clinically important effect on incisional SSI [risk ratio (RR) 1.04, 95% confidence interval (CI) 0.83-1.30], whereas four small trials with some concerns showed a homogeneous reduction (RR 0.41, 0.28-0.59; I²=0%). The overall estimate was heterogeneous and non-significant (RR 0.54, 0.27-1.06; I²=67%; 95% prediction interval 0.09-3.02) and, being dominated by the single large trial, is not interpreted as a single effect; in leave-one-out analysis it became significant only when that trial was removed. Length of hospital stay (ratio of means 0.96, 0.86-1.07) and 30-day mortality (RR 0.95, 0.46-1.96) showed no difference. Among secondary outcomes, seroma was lower with ciNPWT (RR 0.59) and fascial dehiscence was uninformative (RR 1.15); the apparent SSI reduction was confined to the more subjectively assessed superficial component (RR 0.49), with no effect on deep SSI (RR 1.01). Certainty was low for the low-risk estimate (no benefit) and very low for the some-concern estimate (apparent benefit). Current evidence does not provide even low-certainty support that ciNPWT reduces SSI after emergency laparotomy; adequately powered trials with masked outcome assessment are needed.